Topic: Procrit
LOS ANGELES (Reuters) - The Medicare federal health insurance program has confirmed plans to remove a requirement that kidney dialysis providers keep patient hemoglobin levels above a set minimum -- a move likely to reduce use of Epogen, the anemia drug sold by Amgen ...
LOS ANGELES (Reuters) - The Medicare federal health insurance program has proposed removing its requirement that kidney dialysis providers keep patient hemoglobin levels above a set minimum, which could lead to lower use of Epogen, the anemia drug sold by Amgen.The government ...
LOS ANGELES (Reuters) - Medicare officials do not plan at this time to change payment terms for anemia drugs used in kidney patients who are undergoing dialysis.The agency, which is slated to issue a final decision on the matter in June, also ...
BALTIMORE, Maryland (Reuters) - There is not enough data to prove widely used anemia drugs made by Amgen Inc and Johnson & Johnson improve outcomes for kidney patients who undergo organ transplantation, a U.S. Medicare advisory panel said on Wednesday.Advisors to the ...
Recent USRDS (United States Renal Data System) data shows that at least 40% of ESRD patients currently on dialysis, and who are being treated with an anemia drug (such as EPOgen or PROcrit) have an actual red blood cell count above the ...
Would you like to save money on your next prescription of Procrit? Procrit is a man-made protein, which is made from human plasma that allows the body to produce red blood cells. Side effects of Procrit include very serious risks such as ...
Summary Box: FDA panel says anemia drugs should remain available for kidney disease patientsVOTE OF CONFIDENCE: A Food and Drug Administration panel of medical experts voted overwhelmingly to allow anemia drugs from Amgen Inc. to remain approved for patients with kidney disease ...
Federal health advisers said Monday that patients with failing kidneys should continue taking a group of widely used anemia drugs, despite a recent study showing they can increase the risk of stroke.A panel of Food and Drug Administration experts voted 15-1 ...
FDA weighs restrictions of Amgen anemia drugs linked to stroke in kidney disease patientsThe Food and Drug Administration is considering new restrictions on widely used anemia drugs that appear to double the risk of stroke in patients with kidney disease.The FDA ...
Amgen recalls some lots of anemia treatments Epogen and Procrit due to glass flakesABOUT THE RECALL: Some lots of the blockbuster anemia treatments Epogen and Procrit were recalled because the injected drugs may contain glass flakes. Those could cause blood clots, swelling ...
Video Gallery
-
Procrit Commercial 2
The second commercial for Procrit, an antianemia drug that was ...2008-01-31 -
Angie's Aranesp Injection (Equivalent to ...
I was nervous making this video so some of the ...2009-03-13 -
Procrit TV Ad (2003)
Video # 115: A television advertisement for Procrit (epoetin alfa) aired ...2010-08-07
